跳至主要内容
临床试验/CTRI/2022/10/046564
CTRI/2022/10/046564尚未招募不适用

Prospective PeriOperative study Evaluating Routine Coagulation versus Thromboelastography for Liver resections (PORTAL 2 Trial )

TRAC1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年10月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
The primary aim of our study is to study the serial changes of conventional coagulational tests and thromboelastography in cirrhotic patients undergoing major liver resection during perioperative period

研究概览

简要总结

The purpose of our study is to study the serial changes of conventional coagulation tests and thromboelastography (both are tests for assessing the clotting status of the patient) during post operative period in patients undergoing major liver resection (more than 3 segment).

Unlike traditional coagulation assays, which measure components of blood and portions of the coagulation pathway separately, TEG uses whole blood to measure functional coagulation. This allows for active involvement of the red blood cell, white blood cell, platelet and plasma components of coagulation.

Bleeding and vascular thrombosis are major life threatening complications following liver surgery. Following major hepatectomty, there will be altered clotting status, do even when the routine tests are high and TEG is normal, blood transfusions can be avoided, and complications from blood transfusions can be avoided.

This study will be initiated after approval from the institutional ethics committee and registration with CTRI. 20 patients with cirrhosis as determined by Fibroscan posted for liver resection other than those meeting exclusion criteria will be included in this prospective interventional study. Consent for the participation in the study will be taken from all eligible patients. Blood samples will be taken from the patient after getting admitted in hospital. The patient will be taken blood samples at five point of time 1. Preincision (after anaesthetized and before surgery), 2. During intraop (during surgery time as per ot anaesthetist), 3. Immediately after surgery, 4. At 48 hrs and 5. On day 5. Blood samples will be taken for CBC (normal blood test for hemoglobin, and cell counts), routine coagulation tests and TEG.

In this study patient’s medical records will be assessed for the demographic details (age, sex, and weight etc.), clinical data (primary diagnosis and details of surgery) and the blood test reports will be recorded at various intervals as per study design

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • 20 patients with cirrhosis as determined by Fibroscan (Fibrosis score 4) posted for liver resection will be included in the study.

排除标准

  • On therapeutic doses of thromboprophylaxis , Abnormal coagulation or platelets , Any known coagulation disorders , Refusal of consent , Fibrosis score ≤ F3.

结局指标

主要结局

The primary aim of our study is to study the serial changes of conventional coagulational tests and thromboelastography in cirrhotic patients undergoing major liver resection during perioperative period

时间窗: 1.Preincision | 2.Intraoperative (based at discretion of OT anaesthetists) | 3.Postoperative | 4.48 hrs post surgery | 5.5th post surgery

次要结局

  • 1. To record the incidence of prevention of transfusion of blood products(2. Incidence of complications)

研究者

发起方
TRAC
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验